Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1825352-65-5
Purity
95%
Risdiplam is an orally bioavailable mRNA splicing modifier used for the treatment of spinal muscular atrophy. It increases systemic SMN protein concentrations by improving the efficiency of SMN2 gene transcription.
Properties
Name
Risdiplam
Smiles
CC1=CN2N=C(C=C(C)C2=N1)C3=CC(=O)N4C=C(C=CC4=N3)N5CCNC6(CC6)C5
Targets
Please log in to see this information
SDS
RG7916 | risdiplam
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$39
2 mg
$41
5 mg
$43
10 mg
$45
15 mg
$47
20 mg
$50
25 mg
$55
30 mg
$59
35 mg
$62
40 mg
$64
45 mg
$67
50 mg
$69
75 mg
$72
100 mg
$74
Quantity
1
Total amount
$ 43
RG7916 | risdiplam
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.